tiprankstipranks
Actinogen Medical Limited (DE:3AC)
FRANKFURT:3AC
Holding DE:3AC?
Track your performance easily

Actinogen Medical Limited (3AC) Financial Statements

0 Followers

Actinogen Medical Limited Financial Overview

Actinogen Medical Limited's market cap is currently ―. The company's EPS TTM is €-0.003; its P/E ratio is -3.94; Actinogen Medical Limited is scheduled to report earnings on February 20, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 22Jun 21Jun 20Jun 19Jun 18
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT-----
EBITDA-----
Net Income Common Stockholders-----
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsAU$ 16.37MAU$ 13.42MAU$ 5.04MAU$ 7.64MAU$ 10.00M
Total AssetsAU$ 23.31MAU$ 18.38MAU$ 11.94MAU$ 16.22MAU$ 18.03M
Total DebtAU$ 165.27KAU$ 236.44KAU$ 389.87KAU$ 0.00AU$ 0.00
Net DebtAU$ -16.21MAU$ -13.19MAU$ -4.65MAU$ -7.64MAU$ -10.00M
Total LiabilitiesAU$ 1.57MAU$ 920.32KAU$ 1.05MAU$ 557.39KAU$ 768.25K
Stockholders EquityAU$ 21.74MAU$ 17.46MAU$ 10.89MAU$ 15.66MAU$ 17.26M
Cash Flow-
Free Cash Flow-----
Operating Cash Flow-----
Investing Cash Flow-----
Financing Cash Flow-----
Currency in AUD

Actinogen Medical Limited Earnings and Revenue History

Actinogen Medical Limited Debt to Assets

Actinogen Medical Limited Cash Flow

Actinogen Medical Limited Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis